Quantum-Si Inc
QSI1.440USD
-0.020-1.37%
Cierre 08/04, 16:00（ET）Cotizaciones retrasadas 15 min
264.24MCap. mercado
PérdidaP/E TTM
Más Datos de Quantum-Si Inc Compañía
Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.
Información de la empresa
Símbolo de cotizaciónQSI
Nombre de la empresaQuantum-Si Inc
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMr. Jeffrey Alan (Jeff) Hawkins
Número de empleados143
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 04
Dirección29 Business Park Drive
CiudadBRANFORD
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal06405
Teléfono12034587100
Sitio Webhttps://www.quantum-si.com/
Símbolo de cotizaciónQSI
Fecha de salida a bolsaSep 04, 2020
Director ejecutivoMr. Jeffrey Alan (Jeff) Hawkins
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Independent Director
Independent Director
2.92M
+0.23%
Mr. Jeffrey Alan (Jeff) Hawkins
Mr. Jeffrey Alan (Jeff) Hawkins
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.91M
-1.23%
Mr. Jeffry R. (Jeff) Keyes
Mr. Jeffry R. (Jeff) Keyes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
919.45K
-0.93%
Dr. Christian LaPointe, Ph.D.
Dr. Christian LaPointe, Ph.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
854.42K
-1.38%
Mr. Todd C. Bennett
Mr. Todd C. Bennett
Chief Commercial Officer
Chief Commercial Officer
718.49K
+40.84%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
355.00K
--
Ms. Ruth A. Fattori
Ms. Ruth A. Fattori
Independent Director
Independent Director
170.51K
+4.18%
Ms. Paula Dowdy
Ms. Paula Dowdy
Independent Director
Independent Director
53.07K
-66.67%
Mr. Scott Mendel
Mr. Scott Mendel
Independent Director
Independent Director
47.28K
+33.33%
Mr. Amir Jafri
Mr. Amir Jafri
Independent Director
Independent Director
38.65K
-66.67%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Kevin L. Rakin
Mr. Kevin L. Rakin
Independent Director
Independent Director
2.92M
+0.23%
Mr. Jeffrey Alan (Jeff) Hawkins
Mr. Jeffrey Alan (Jeff) Hawkins
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.91M
-1.23%
Mr. Jeffry R. (Jeff) Keyes
Mr. Jeffry R. (Jeff) Keyes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
919.45K
-0.93%
Dr. Christian LaPointe, Ph.D.
Dr. Christian LaPointe, Ph.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
854.42K
-1.38%
Mr. Todd C. Bennett
Mr. Todd C. Bennett
Chief Commercial Officer
Chief Commercial Officer
718.49K
+40.84%
Mr. Charles R. (Chuck) Kummeth
Mr. Charles R. (Chuck) Kummeth
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
355.00K
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 13 de jun
Actualizado: vie., 13 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Rothberg (Jonathan M)
7.56%
BlackRock Institutional Trust Company, N.A.
4.86%
The Vanguard Group, Inc.
4.77%
ARK Investment Management LLC
4.38%
Nikko Asset Management Co., Ltd.
3.09%
Other
75.34%
Accionistas
Accionistas
Proporción
Rothberg (Jonathan M)
7.56%
BlackRock Institutional Trust Company, N.A.
4.86%
The Vanguard Group, Inc.
4.77%
ARK Investment Management LLC
4.38%
Nikko Asset Management Co., Ltd.
3.09%
Other
75.34%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
16.53%
Individual Investor
12.61%
Investment Advisor/Hedge Fund
8.36%
Hedge Fund
3.53%
Research Firm
0.64%
Holding Company
0.41%
Venture Capital
0.20%
Family Office
0.12%
Bank and Trust
0.10%
Other
57.49%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
267
77.14M
42.46%
-882.28K
2025Q1
278
76.41M
46.71%
+317.44K
2024Q4
271
68.59M
42.10%
-6.57M
2024Q3
252
70.04M
55.68%
-7.45M
2024Q2
247
70.14M
56.56%
-4.69M
2024Q1
255
69.57M
56.30%
-9.44M
2023Q4
250
68.72M
56.32%
-9.91M
2023Q3
261
68.63M
56.31%
-5.37M
2023Q2
261
63.23M
52.14%
-15.03M
2023Q1
275
75.54M
63.26%
-9.35M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Rothberg (Jonathan M)
13.73M
8.4%
--
--
Mar 03, 2025
BlackRock Institutional Trust Company, N.A.
8.83M
5.4%
+934.37K
+11.83%
Mar 31, 2025
The Vanguard Group, Inc.
6.89M
4.21%
+1.40M
+25.51%
Mar 31, 2025
ARK Investment Management LLC
7.81M
4.77%
-904.16K
-10.38%
May 31, 2025
Nikko Asset Management Co., Ltd.
5.81M
3.55%
-153.78K
-2.58%
Mar 31, 2025
Millennium Management LLC
3.93M
2.41%
+3.93M
--
Mar 31, 2025
Geode Capital Management, L.L.C.
2.99M
1.83%
+626.51K
+26.45%
Mar 31, 2025
Rakin (Kevin L)
2.92M
1.78%
+6.84K
+0.23%
Mar 03, 2025
State Street Global Advisors (US)
2.45M
1.5%
+49.09K
+2.04%
Mar 31, 2025
Hawkins (Jeffrey Alan)
1.91M
1.17%
-23.70K
-1.23%
Jun 23, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
ARK Genomic Revolution ETF
1.5%
Vanguard US Momentum Factor ETF
0.08%
iShares Micro-Cap ETF
0.06%
iShares Russell 2000 Value ETF
0.02%
ProShares Hedge Replication ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
iShares Russell 2000 ETF
0.01%
Ver más
ARK Genomic Revolution ETF
Proporción1.5%
Vanguard US Momentum Factor ETF
Proporción0.08%
iShares Micro-Cap ETF
Proporción0.06%
iShares Russell 2000 Value ETF
Proporción0.02%
ProShares Hedge Replication ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Global X Russell 2000 ETF
Proporción0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.01%
iShares Russell 2000 ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
